Redeye comments on Acarix following recent news relating to the ownership structure, where, among ot...
Redeye updates its view on Thunderful. Atari’s majority acquisition (80%) of Thunderful offers clear...
Biovica records SEK 2.6m in total net sales (51% above Q1 last year), and clinical sales increased b...
Redeye makes an initial comment about the new targets and cost savings.
Redeye comments on OncoZenge’s announcement of appointing LINK Medical as CRO for its pivotal phase ...
Smart Eye secures a milestone AIS order from fleet safety provider Optix, marking the first large-sc...
Redeye return with a research update following BioArctic's Q2 and latest newsflow.
In May, Endomines unveiled its updated strategy for 2025–2029.
With additional funds and a streamlined organisation, Sprint Bioscience continues to proactively pro...
This morning, Alligator announced the launch of a new investigator-sponsored phase II/III trial with...
This adds to the initial evaluation announced by Q-linea’s regional partner earlier this year.
This morning, Litium announced the acquisition of Geins, a SaaS e-commerce platform with strong AI a...
Vi inleder bevakning på Acenta Group, en internationell helhetsleverantör inom padelbranschen.
According to Financial Times, China is hitting EU pork imports with up to 62% anti-dumping levies.
Cell Impact står fortsatt inför stora utmaningar. Q2-rapporten för 2025 visar en omsättning på 2,1 M...
Redeye is positive about the FDA clearance to expand the labeling of the Prism system.
Botnia Gold redovisade ett starkt andra kvartal med intäkter på 115 Mkr och ett rörelseresultat på 4...
mResell redovisade totala intäkter om 26,5 MSEK, varav nettoomsättningen uppgick till 25,5 MSEK, akt...
Redeye comments on Initiator Pharma’s announcement that it has submitted a CTA to the UK authorities...
